Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 154,364 | 152,125 | 142,944 | 141,364 | 136,501 |
| Cost of Goods | 94,779 | 94,143 | 89,795 | 87,889 | 84,101 |
| Gross Profit | 59,585 | 57,982 | 53,149 | 53,475 | 52,400 |
| Operating Expenses | 25,358 | 24,277 | 22,989 | 21,845 | 22,119 |
| Operating Income | 35,006 | 33,848 | 30,955 | 32,519 | 30,382 |
| Interest Expense | 2,170 | 2,040 | 2,053 | 2,289 | 2,958 |
| Other Income | 891 | 436 | 676 | -177 | 244 |
| Pre-tax Income | 33,727 | 32,244 | 29,578 | 30,053 | 27,668 |
| Income Tax | 12,985 | 12,414 | 11,387 | 10,805 | 10,721 |
| Net Income Continuous | 20,561 | 19,354 | 17,505 | 18,531 | 16,328 |
| Net Income | $20,561 | $19,354 | $17,505 | $18,531 | $16,328 |
| EPS Basic Total Ops | 0.45 | 0.43 | 0.39 | 0.41 | 0.37 |
| EPS Basic Continuous Ops | 0.45 | 0.43 | 0.39 | 0.41 | 0.37 |
| EPS Diluted Total Ops | 0.42 | 0.40 | 0.39 | 0.38 | 0.34 |
| EPS Diluted Continuous Ops | 0.40 | 0.38 | 0.36 | 0.36 | 0.32 |
| EBITDA(a) | $42,458 | $41,028 | $37,856 | $39,358 | $36,561 |